Argyle Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,462
Closed -$252K 126
2022
Q2
$252K Sell
7,462
-81
-1% -$2.84K 0.09% 120
2022
Q1
$263K Sell
7,543
-356
-5% -$12.2K 0.09% 120
2021
Q4
$241K Sell
7,899
-270
-3% -$8.79K 0.08% 119
2021
Q3
$268K Sell
8,169
-130
-2% -$4.16K 0.09% 118
2021
Q2
$251K Buy
+8,299
New +$273K 0.08% 122

Other funds holding OGN

Argyle Capital Management's OGN Position: Q3 2022 in Review

Argyle Capital Management sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 7,462 shares — an estimated $252K sold.

Argyle Capital Management first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $268K in Q3 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Argyle Capital Management reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Argyle Capital Management sold 7,462 Organon & Co shares in Q3 2022, an estimated $252K.
  • Argyle Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Argyle Capital Management's Organon & Co position peaked at $268K in Q3 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Argyle Capital Management's 13F filing for Q3 2022, filed 21 Oct 2022.